FTC’s Crackdown on Pharma Mergers Reflects ‘Tougher’ M&A Environment Under Biden Administration: Lawyer
March 22, 2021
By: Eric Sagonowsky
FiercePharma
Axinn partner Jeny Maier was quoted in the FiercePharma article, "FTC's Crackdown on Pharma Mergers Reflects 'Tougher' M&A Environment Under Biden Administration: Lawyer." This quote also appeared in the April 21, 2021 Forbes article, “After Roaring in 2020, Biotech Stocks Now Weighed Down By Merger Scrutiny, FDA Approval Delays and Possible Drug Pricing Legislation.”
Click here to access the article.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
ACI Forum on Pharma & Biotech Patent Litigation USA 2025
Speaking Engagement
Intellectual Property
CCWC 21st Annual Career Strategies Conference
Speaking Engagement
Fordham 52nd Annual Conference on International Antitrust Law and Policy
Speaking Engagement
Antitrust
Kisaco Research Trade Secret Legal Protection Conference 2025
Speaking Engagement
Intellectual Property
SCCE 23rd Annual Compliance & Ethics Institute
Speaking Engagement
Antitrust
29th Annual IBA Competition Conference
Sponsorship
Antitrust
Key Appellate Decisions Shaping Antitrust Strategy
Webinar
Antitrust
New Frontiers of Antitrust – 16th Annual International Conference of Concurrences Review
Speaking Engagement
Antitrust
MCCA Pathways Conference
Sponsorship
Antitrust
HNBA/VIA Annual Convention 2025
Sponsorship
Antitrust